Monthly Archives: June 2009

Is FDA Picking Up the Regulatory Pace?

Posted on June 30, 2009 by Mark Senak

It seems early in the oversight of the new FDA Commissioner and Deputy Commissioner to the agency turning a corner, or maybe not. There have been two indications of possible increased enforcement that have emerged in the past few days … Continue reading →

Posted in FDA Policy | 1 Comment

Weekly Roundup – 6/26/09

Posted on June 26, 2009 by Mark Senak

We have had 3 days in a row without rain.  That is most welcome.  Today, I fear, we may lose our streak.  It has heated up in Washington and so has the debate on healthcare reform.  Another public figure who … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 6/26/09

Opps for Apps

Posted on June 24, 2009 by Mark Senak

It is no state secret that the pharmaceutical industry is seriously lagging behind other industries – even other highly regulated industries – in making use of digital media to engage and support their stakeholders.  There are still many, if not … Continue reading →

Posted in New and Social Media | 5 Comments

FDA’s Transparency Meeting

Posted on June 23, 2009 by Mark Senak

Tomorrow, the FDA is holding a hearing on transparency here in Washington, D.C and have issued their ground rules for participation.   The event is certainly a noble gesture and one does not have reason to expect that this time around, FDA is anything … Continue reading →

Posted in FDA Policy | 1 Comment

The Growing Importance of Twitter

Posted on June 23, 2009 by Mark Senak

I happen to think that no element of new and emerging media is more important than Twitter – something that should be apparent to anyone involved in communications. Enter into evidence the role that Twitter played in many recent news … Continue reading →

Posted in New and Social Media | Comments Off on The Growing Importance of Twitter